Previously, we reported that STING/IFN-I signaling promoted LLC tumor growth due to increased local immune regulation mediated by TDLN DCs expressing IDO.12 In the current study, we tested if direct CDA treatment controlled growth of LLC tumors. The gene discussed is STING1; the disease is neoplasm.